UK markets open in 7 hours 24 minutes

Oncternal Therapeutics, Inc. (GTU.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.0000-6.5200 (-100.00%)
At close: 09:00AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
29,753
29,753
32,980
24,086
12,544
Selling general and administrative
12,746
12,746
13,457
11,595
8,373
Total operating expenses
41,714
41,714
44,947
31,366
17,542
Operating income or loss
-41,714
-41,714
-44,947
-31,366
-17,542
Interest expense
0
-
-
-
-
Total other income/expenses net
-
-
-
-
301
Income before tax
-39,479
-39,479
-44,170
-31,333
-17,225
Income from continuing operations
-39,479
-39,479
-44,170
-31,333
-17,225
Net income
-39,479
-39,479
-44,170
-31,333
-17,225
Net income available to common shareholders
-39,479
-39,479
-44,170
-31,333
-17,225
Basic EPS
-14.40
-13.43
-16.80
-12.80
-17.00
Diluted EPS
-14.40
-13.43
-16.80
-12.80
-17.00
Basic average shares
2,910
2,940
2,630
2,466
1,015
Diluted average shares
2,910
2,940
2,630
2,466
1,015